Anti-SLC37A1 monoclonal antibody

Pre-made anti-SLC37A1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SLC37A1/SLC37A1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1728-Ab-1/ GM-Tg-hg-IP1728-Ab-2Anti-Human SLC37A1 monoclonal antibodyHuman
GM-Tg-rg-IP1728-Ab-1/ GM-Tg-rg-IP1728-Ab-2Anti-Rat SLC37A1 monoclonal antibodyRat
GM-Tg-mg-IP1728-Ab-1/ GM-Tg-mg-IP1728-Ab-2Anti-Mouse SLC37A1 monoclonal antibodyMouse
GM-Tg-cynog-IP1728-Ab-1/ GM-Tg-cynog-IP1728-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC37A1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1728-Ab-1/ GM-Tg-felg-IP1728-Ab-2Anti-Feline SLC37A1 monoclonal antibodyFeline
GM-Tg-cang-IP1728-Ab-1/ GM-Tg-cang-IP1728-Ab-2Anti-Canine SLC37A1 monoclonal antibodyCanine
GM-Tg-bovg-IP1728-Ab-1/ GM-Tg-bovg-IP1728-Ab-2Anti-Bovine SLC37A1 monoclonal antibodyBovine
GM-Tg-equg-IP1728-Ab-1/ GM-Tg-equg-IP1728-Ab-2Anti-Equine SLC37A1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1728-Ab-1/ GM-Tg-hg-IP1728-Ab-2; GM-Tg-rg-IP1728-Ab-1/ GM-Tg-rg-IP1728-Ab-2;
GM-Tg-mg-IP1728-Ab-1/ GM-Tg-mg-IP1728-Ab-2; GM-Tg-cynog-IP1728-Ab-1/ GM-Tg-cynog-IP1728-Ab-2;
GM-Tg-felg-IP1728-Ab-1/ GM-Tg-felg-IP1728-Ab-2; GM-Tg-cang-IP1728-Ab-1/ GM-Tg-cang-IP1728-Ab-2;
GM-Tg-bovg-IP1728-Ab-1/ GM-Tg-bovg-IP1728-Ab-2; GM-Tg-equg-IP1728-Ab-1/ GM-Tg-equg-IP1728-Ab-2
Products NameAnti-SLC37A1 monoclonal antibody
Formatmab
Target NameSLC37A1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SLC37A1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1728-Ag-1Recombinant multi-species G6PT2/ SLC37A1/ G3PP protein


    Target information

    Target IDGM-IP1728
    Target NameSLC37A1
    Gene ID54020,224674,294321,714337,487780,101093794,511558,100051207
    Gene Symbol and SynonymsG3PP,SLC37A1,SPX1
    Uniprot AccessionP57057
    Uniprot Entry NameG6PT2_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000160190
    Target ClassificationN/A

    The target: SLC37A1, gene name: SLC37A1, also named as G3PP. The protein encoded by this gene localizes to the endoplasmic reticulum (ER) membrane. This protein translocates glucose-6-phosphate from the cytoplasm into the lumen of the ER for hydrolysis into glucose by another ER membrane protein. This gene is a member of the solute carrier 37 gene family. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.